These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7502746)

  • 21. Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA.
    Calcedo R; Ramirez-Garcia A; Abad A; Rementeria A; Pontón J; Hernando FL
    Rev Iberoam Micol; 2012; 29(3):172-4. PubMed ID: 21906693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA subclass responses to lipopolysaccharide in humans.
    Moldoveanu Z; Brown TA; Ventura MT; Michalek SM; McGhee JR; Mestecky J
    Adv Exp Med Biol; 1987; 216B():1199-205. PubMed ID: 3425426
    [No Abstract]   [Full Text] [Related]  

  • 23. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.
    Wozniak KL; Leigh JE; Hager S; Swoboda RK; Fidel PL
    J Infect Dis; 2002 May; 185(9):1269-76. PubMed ID: 12001044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary IgA subclasses and bacteria-reactive IgA in patients with aggressive periodontitis.
    Hägewald S; Bernimoulin JP; Köttgen E; Kage A
    J Periodontal Res; 2002 Oct; 37(5):333-9. PubMed ID: 12366855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-positive patients and modified by oral candidiasis.
    Coogan MM; Challacombe SJ
    Oral Microbiol Immunol; 2000 Oct; 15(5):284-9. PubMed ID: 11154418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of Candida albicans germ tubes with salivary secretory IgA.
    Pontón J; Bikandi J; Moragues MD; Arilla MC; Elósegui R; Quindós G; Fisicaro P; Conti S; Polonelli L
    J Dent Res; 1996 Dec; 75(12):1979-85. PubMed ID: 9033453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: a systematic review.
    Pomarico L; de Souza IP; Castro GF; Teles RP; Luiz RR; Maia LC
    J Dent; 2010 Jan; 38(1):10-5. PubMed ID: 19761812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired secretory immunity in dystrophic epidermolysis bullosa.
    Sweet SP; Ballsdon AE; Harris JC; Roberts GJ; Challacombe SJ
    Oral Microbiol Immunol; 1999 Oct; 14(5):316-20. PubMed ID: 10551159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.
    Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T
    Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum and saliva antibodies to Candida and isolation of Candida species from the mucosa of HIV-infected individuals.
    Castro G; Martinez R
    Mycoses; 2009 May; 52(3):246-50. PubMed ID: 18643885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines.
    Brown TA; Clements ML; Murphy BR; Radl J; Haaijman JJ; Mestecky J
    Adv Exp Med Biol; 1987; 216B():1691-700. PubMed ID: 3425456
    [No Abstract]   [Full Text] [Related]  

  • 33. Nonspecific secretory immunity in HIV-infected patients with oral candidiasis.
    Bard E; Laibe S; Clair S; Biichlé S; Millon L; Drobacheff C; Bettinger D; Seillès E; Meillet D
    J Acquir Immune Defic Syndr; 2002 Nov; 31(3):276-84. PubMed ID: 12439202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of humoral responses to Candida in HIV infection.
    Wray D; Felix DH; Cumming CG
    Br Dent J; 1990 Apr; 168(8):326-9. PubMed ID: 2185811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonspecific oral immunity in individuals with HIV infection.
    Müller F; Holberg-Petersen M; Rollag H; Degré M; Brandtzaeg P; Frøland SS
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):46-51. PubMed ID: 1371157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotype, subclass and molecular size of immunoglobulins in salivas from young infants.
    Smith DJ; King WF; Taubman MA
    Clin Exp Immunol; 1989 Apr; 76(1):97-102. PubMed ID: 2736804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and salivary immunoglobulin A and free secretory component in ulcerative colitis.
    Morris TJ; Matthews N; Rhodes J
    Clin Allergy; 1981 Nov; 11(6):561-4. PubMed ID: 7037222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.
    Benjelloun F; Dawood R; Urcuqui-Inchima S; Rochereau N; Chanut B; Verrier B; Lucht F; Genin C; Paul S
    AIDS; 2013 Jul; 27(12):1992-5. PubMed ID: 23696073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
    Funkhouser A; Clements ML; Slome S; Clayman B; Viscidi R
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):627-32. PubMed ID: 8369168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.